Thyroid Pill Recall: Superpotent Batch | US News

Vitruvias Therapeutics is recalling a specific lot of its 30-mg thyroid tablets after discovering they’re dangerously overpotent—potentially causing hyperthyroidism symptoms like weight loss, heat intolerance, and heart issues. The recalled batch, lot 504950 (expiring 9/30/2026), was distributed nationwide between Jan 31 and Sept 30 last year and affected nearly 2,000 units sold in the U.S. Made from natural porcine thyroid glands, the drug treats hypothyroidism, but excess potency poses serious risks—especially for older adults, pregnant women, and infants. While no adverse reactions have been reported yet, patients should consult their doctor before discontinuing treatment. This follows a recent recall from Major Pharmaceuticals for underpotent pills—highlighting how critical precise dosing is for thyroid medications. Listen in comfort:Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/9da0bd31bf339ab7